Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Guerline Clerzius"'
Autor:
Oloruntoba Oluboka, Guerline Clerzius, Wolfgang Janetzky, Daniel Schöttle, François Therrien, Klaus Wiedemann, Marc-André Roy
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Functional impairment affects many patients with schizophrenia. Treatment with the long-acting injectable antipsychotic aripiprazole once-monthly (AOM) may help improve functioning. Objectives To explore changes in functioning in
Externí odkaz:
https://doaj.org/article/b41414ee9b7c4325967bcb2efd486c17
Publikováno v:
BMC Psychiatry, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background ReLiAM, Real-Life Assessment of Abilify Maintena, was the first reported long-term prospective non-interventional study for patients with schizophrenia treated with aripiprazole once-monthly injectable formulation (AOM) under real
Externí odkaz:
https://doaj.org/article/6dca78017f6c4341a9f08f1907825ea2
Autor:
Daniel Schöttle, Guerline Clerzius, Wolfgang Janetzky, Oloruntoba Oluboka, Marc-André Roy, François Therrien, Klaus Wiedemann
Publikováno v:
European Psychiatry, Vol 65 (2022)
AbstractBackgroundNoninterventional naturalistic studies are an important complement to randomized controlled trials. Aripiprazole once-monthly (AOM) is an atypical antipsychotic in a long-acting injectable formulation.MethodsA pooled analysis of two
Externí odkaz:
https://doaj.org/article/c1f5b4ef65794bbd9a012797acb20b7e
Autor:
Sally Mustafa, Joanna Bougie, Maia Miguelez, Guerline Clerzius, Emmanouil Rampakakis, Jean Proulx, Ashok Malla
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background With previously established efficacy of aripiprazole once-monthly injectable formulation (AOM) in pre-registration randomized controlled trials, the current study was designed to evaluate its effectiveness in patients treated for
Externí odkaz:
https://doaj.org/article/19927ee0c8364dba8fc62eb38a4d51b4
Publikováno v:
Therapeutic Advances in Psychopharmacology, Vol 11 (2021)
Background: Anxiety symptoms are common in patients with major depressive disorder (MDD) and usually confer worse treatment outcomes. The long-term, open-label AtWoRC study in working patients with MDD treated with vortioxetine demonstrated a signifi
Externí odkaz:
https://doaj.org/article/541a0df380b2467485891daa473ef746
Autor:
Eileen Shaw, Lucile Sinck, Guerline Clerzius, Rekha C. Patel, Aïcha Daher, Jean-François Gélinas, Thornin Ear, Andrew J. Mouland, Jean-Pierre Routy, Samantha Burugu, Anne Gatignol
Publikováno v:
Retrovirology
Background HIV-1 translation is modulated by the activation of the interferon (IFN)-inducible Protein Kinase RNA-activated (PKR). PKR phosphorylates its downstream targets, including the alpha subunit of the eukaryotic translation Initiation Factor 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91aac044784f392490cc6578caee06ee
https://doi.org/10.1186/1742-4690-10-96
https://doi.org/10.1186/1742-4690-10-96
Autor:
Joanna Bougie, Emmanouil Rampakakis, Maia Miguelez, Sally Mustafa, Jean Proulx, Ashok Malla, Guerline Clerzius
Publikováno v:
BMC Psychiatry, Vol 19, Iss 1, Pp 1-9 (2019)
BMC Psychiatry
BMC Psychiatry
Background With previously established efficacy of aripiprazole once-monthly injectable formulation (AOM) in pre-registration randomized controlled trials, the current study was designed to evaluate its effectiveness in patients treated for schizophr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e70bac7134c650f1e4d8c8083afef0cf
https://doi.org/10.1186/s12888-019-2103-x
https://doi.org/10.1186/s12888-019-2103-x
Autor:
Mustafa, Sally, Bougie, Joanna, Miguelez, Maia, Guerline Clerzius, Rampakakis, Emmanouil, Proulx, Jean, Malla, Ashok
Table S1. Adherence rate to AOM from first to last injection. (DOCX 14 kb)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f0b4358b10bbdde825b040223e217ff
Publikováno v:
Therapeutic Advances in Psychopharmacology
Therapeutic Advances in Psychopharmacology, Vol 11 (2021)
Therapeutic Advances in Psychopharmacology, Vol 11 (2021)
Background: Anxiety symptoms are common in patients with major depressive disorder (MDD) and usually confer worse treatment outcomes. The long-term, open-label AtWoRC study in working patients with MDD treated with vortioxetine demonstrated a signifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105f49b3cdd42f725025ba57f990f56d
https://doi.org/10.1177/20451253211013148
https://doi.org/10.1177/20451253211013148
Publikováno v:
Reviews in Medical Virology. 21:42-53
Recent therapeutic approaches against HIV-1 include IFN in combination therapy for patients with coinfections or as an alternative strategy against the virus. These treatment options require a better understanding of the weak efficacy of the IFN-stim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad721788a26a104ee4d79f4ef66dee09
https://doi.org/10.1002/rmv.674
https://doi.org/10.1002/rmv.674